Northern New Jersey

CEO Report Northern New Jersey

Top Stories

Northern New Jersey, August 10, 2018


A Consumer Reports survey released this week found Google Fiber’s TV service to the best among the 25 providers evaluated. Only 38 percent of the 176,000 members surveyed were highly-satisfied with pay-TV services. Read more at The New York Post.



Simmons Foundation has entered into an agreement to purchase the office section of the 150,000-square-foot property at 160 Fifth Ave. from RFR Holdings for $185 million. RFR bought the building for $34 million in 2005 and will maintain control of the retail part of the building. Read more at BisNow.



New York City Council voted to freeze new vehicle licensing for ride-share services for a period of one year in effort to ease traffic congestion in the city. New York is the first city in the county to put limits on such services. Read more at the New York Business Journal.



The city’s Landmarks Preservation Commission approved Nexus Building Development’s proposal for a residential building at the site of a former East Village gas explosion. When complete, the seven-story structure will bring 21 condos to the neighborhood with ground-floor retail. Read more at Curbed New York.



Seattle’s Finance and Administrative Services department reported the city has collected $5.8 million in revenue from its newly imposed soda tax in the second quarter of 2018. The 1.75 cent per fluid ounce tax went into effect six months ago and has collected $10.5 million in taxes since the beginning of the year. Read more at Fox Business.

CEO Report TV

Bart Jackson, CEO, Bart’s Books

Alan Rihm, CEO, CoreDial

John Iatesta, CEO, Veptas Technology Solutions

Our Most Recent Features

Industry City’s Massive Rezoning Proposal

DEVELOPMENT In 2017, Industry City, a collection of 16 massive warehouses located on the neighborhood’s western edge, announced a proposal to rezone its campus, which at six million square feet is already the largest privately-owned industrial complex in New York...

Newell Brands Sells Jostens for $1.3 Billion

RETAIL Jostens Inc., the Minnesota maker of school memorabilia and class and championship rings, will be sold by owner Newell Brands to private equity firm Platinum Equity, the companies said Wednesday. Hoboken, N.J.-based Newell said the Jostens sale would generate...

How Do We Build Smart Cities?

INNOVATION In New Jersey's cities of tomorrow, kitchen appliances could alert homeowners they need to be replaced. Smart meters could tell them how to lower their electric bill. Commuters would be able to use ride-sharing apps to connect them from home or work to the...

ANG Acquires Clark Commercial Center Property for $15.84 Million

COMMERCIAL REAL ESTATE ANG Management has purchased 175-195 Terminal Ave. at the Clark Commercial Center, the home of L’Oreal’s North American R&D division, from Denholtz Associates for $15.84 million. Real estate advisory firm Newmark Knight Frank announced the sale...

In Case You Missed Them

NJ Hospitals Among Best in the Nation

HEALTHCARE Six years after a panel of medical experts began grading hospitals across the country based on their success keeping patients safe and protecting them from infections, falls and mistakes, New Jersey has earned more A's than any other state in the nation, a...

read more

Hospitals Asked to Support Affordable Housing Program

HEALTHCARE The New Jersey Housing and Mortgage Finance Agency has asked hospitals in the state to participate in a $12 million partnership program designed to promote investment in affordable and supportive housing in their communities. Under the Hospital Partnership...

read more

NJIT Created Engineering and Technology School

HIGHER EDUCATION The New Jersey Institute of Technology is creating the School of Applied Engineering and Technology within the university’s Newark College of Engineering, it announced Tuesday. Designed to meet spiraling demand in the job market for applied...

read more

Provention Bio Selected to Test Amgen Celiac Drug

HEALTHCARE Under a deal announced Monday, Provention Bio will license the Amgen drug, AMG714, and test it in a mid-stage study. Amgen had previously licensed the compound to Celimmune, which tested it in two mid-stage studies, then was acquired by the Thousand Oaks,...

read more

Go To Our Archive


Follow CEO Report Northern New Jersey